Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 6/20 | 0.53 |
| ▸ | TNKS | O95271 | 5/20 | 0.40 |
| ▸ | TNKS2 | Q9H2K2 | 5/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | PLAT | P00750 | 7/20 | 0.38 |
| ▸ | CDK9 | P50750 | 1/20 | 0.36 |
| ▸ | HTR6 | P50406 | 2/20 | 0.35 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.34 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1720668 | 0.99 | PARP1 (0.53) | PARP1TNKSTNKS2KCNH2PLAT | |
| SCHEMBL1719886 | 0.89 | PARP1 (0.59) | PARP1TNKSTNKS2CDK9HTR6 | |
| SCHEMBL1720074 | 0.85 | PARP1 (0.76) | PARP1KCNH2 | |
| SCHEMBL1720626 | 0.85 | PARP1 (0.55) | PARP1TNKSTNKS2KCNH2CDK9 | |
| SCHEMBL1719884 | 0.85 | PARP1 (0.71) | PARP1KCNH2PLATDDB1CRBN | |
| SCHEMBL1720505 | 0.84 | PARP1 (0.65) | PARP1KCNH2 | |
| Hydrochloric Acid SCHEMBL1719792 | 0.84 | PARP1 (0.70) | PARP1KCNH2PLATDDB1CRBN | |
| SCHEMBL1720616 | 0.82 | SLC6A4 (0.41) | PARP1TNKSTNKS2KCNH2PLAT | |
| Hydrochloric Acid SCHEMBL1717425 | 0.81 | SLC6A4 (0.41) | PARP1TNKSTNKS2KCNH2PLAT | |
| SCHEMBL1720314 | 0.77 | PARP1 (0.46) | PARP1TNKSTNKS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1566380-B1 | ISOQUINOLINE COMPOUNDS AND MEDICINAL USE THEREOF | MITSUBISHI TANABE PHARMA CORP (JP) | 2012-01-11 | — | — | EP | claimed |
| US-7501412-B2 | Isoquinoline compounds and medicinal use thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-03-10 | — | — | US | disclosed |
| US-7501412-B2 | Isoquinoline compounds and medicinal use thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-03-10 | — | — | US | disclosed |